| Line Item | 2023-01-29 | Y/Y |
|---|---|---|
| Revenue | $26.97B | +0.2% |
| Cost of Revenue | $11.62B | +23.1% |
| Gross Profit | $15.36B | -12.1% |
| R&D Expense | $7.34B | +39.3% |
| SG&A Expense | $2.44B | +12.7% |
| Operating Income | $4.22B | -57.9% |
| Interest Expense | $262.0M | +11.0% |
| Pre-tax Income | $4.18B | -57.9% |
| Income Tax | -$187.0M |
| Line Item | 2023-01-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.39B | +70.3% |
| Short-term Investments | $9.91B | -48.4% |
| Accounts Receivable | $3.83B | -17.7% |
| Inventory | $5.16B | +98.0% |
| Current Assets | $23.07B | -20.0% |
| Total Assets | $41.18B | -6.8% |
| Current Liabilities | $6.56B | +51.4% |
| Line Item | 2023-01-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.64B | -38.1% |
| Investing Cash Flow | $7.38B | +175.0% |
| Financing Cash Flow | -$11.62B | -722.9% |
| -198.9% |
| Net Income | $4.37B | -55.2% |
| EPS (Basic) | $1.76 | -55.0% |
| EPS (Diluted) | $1.74 | -54.8% |
| Long-term Debt |
| $10.95B |
| +0.1% |
| Total Liabilities | $19.08B | +8.6% |
| Stockholders' Equity | $22.10B | -17.0% |